Search

everythinglearnresearchcommunity

for

Search:↓

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Future research on female pattern hair loss should focus on treatment effectiveness, safety, and understanding causes.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Uterine transplants for transgender women are feasible but need more research.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Dogs exposed to their owners' hormone therapy developed hair loss, but symptoms resolved after stopping the therapy.

Spironolactone is used in dermatology to treat skin conditions related to hormones, but is not safe for pregnant women or men.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

Sex hormones affect dog skin conditions, but more data is needed.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Tabby mutations in mice affect hair follicle development and help study genetic mapping and certain medical conditions.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Hair loss can have various causes and treatments vary in effectiveness.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Early hormones shape sex-specific differences in rat glands.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.